Mirena Recall 2012

The Mirena device is an intrauterine form of birth control that is recommended for women who have already had children. In the past year, word spread that there was a Mirena Recall 2012.

The Mirena Recall 2012–A Myth

According to fda.gov, there was no official recall, yet there were many troubling reports of problems associated with the Mirena device. Word of a Mirena Recall 2012 caused many lawsuits to arise. Women considering use of the Mirena device should be aware of potential drawbacks that have been experienced by many users of this method of birth control.

Problems Associated With Mirena

Women who are prone to pelvic infections should not use the Mirena as there is an increased risk of inflammation. In addition, victims of breast, cervical, or uterine cancer should not use the Mirena device. In some cases, women have experienced disruption in their menstrual flow, pelvic discomfort, lack of sex drive, fever and infection. Expulsion of the device may occur, in which the device actually falls out. This can result in pregnancy.

Embedment or Perforation Caused by Mirena

Embedment and perforation are cause for concern for women considering Mirena. During embedment, the device actually becomes attached to the uterus. Conception may occur, other complications, and surgery is likely to remove it. Perforation results when the Mirena actually perforates, or punctures, the uterine wall. Once again, pregnancy and surgery may result. Perforation can result in scarring, infection, and serious damage to the uterus, as well as other organs. A woman may not be able to conceive as a result.

You May Also Like


  • This field is for validation purposes and should be left unchanged.

, , ,

No comments yet.

Leave a Reply

  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Paxil Possibly Linked To Breast Cancer Risk

Cancer researchers from the City of Hope National Medical Center announced a possible link between Paxil and breast cancer. Research focused on Paxil’s estrogen effect Researchers found that Paxil has a weak estrogen effect that could increase women’s breast cancer risks. According to lead author and chairman of City of Hope’s Department of Cancer and […]

Big Pharma under Fire for Kickbacks to Docs

Trust and honesty are the cornerstones to a doctor-patient relationship. With so many doctors receiving financial incentives to use certain medications or medical devices, patients need to know if money drives the decision making process. Doctors are required to disclose potential financial conflicts to each other at conferences, but there currently is no law forcing […]

Dietary Supplements Damage Liver

A recent study revealed a significant increase in liver damage related to dietary supplements. The study, conducted by a national network of liver specialists, found a 13% increase in serious liver damage over a 10 year span. Some of these patients required liver transplants and some have even died due to liver failure. Authors of […]

FDA Advisory Committee Supports Approval of Gilead’s HIV Reducing Drug

The pharmaceutical industry may be on the verge of one of the greatest breakthrough’s that this generation has ever seen.

U.S. Health Regulators Issue New Restrictions For Gilenya, Novartis AG’s’ Multiple Sclerosis Pill

In December 2011, the FDA issued a Drug Safety Communication concerning a patient with multiple sclerosis (MS) who died within 24 hours of taking the first dose of Gilenya (fingolimod).

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.